UNI NOVA – Research Magazine of the University of Basel
-
Alumni
The memoirs of Dieter Imboden.
Dieter Imboden, an environmental researcher and political scientist who spent much of his childhood in Basel, is a past winner of the Alumni Award. He recently published his autobiography.
-
Alumni
An ambassador for German scholarship.
Thomas Maissen studied history, Latin and philosophy at the University of Basel. Today, he is the Director of the German Historical Institute in Paris.
-
Column
Against extremism.
Text: Sandra Schlumpf-Thurnherr / My book: The Spanish Linguist Prof. Sandra Schlumpf-Thurnherr recommends the epistolary novel "Address unknown" by the american writer Kathrine Kressmann Taylor, published in 1938.
-
Dossier
Advancing vision research.
Text: Botond Roska und Hendrik Scholl / The development of new treatments for patients suffering from vision impairments worldwide is the focus of a group of research teams at the new Institute for Molecular and Clinical Ophthalmology Basel (IOB), which is affiliated with the University of Basel, helping to enhance the university’s international reputation.
-
Dossier
Collecting knowledge to combat eye diseases.
Text: Martin Hicklin / Researchers in Basel are investigating treatments for various eye diseases. Botond Roska is focusing on the retina through a series of experiments as well as exploring potential gene therapies.
-
Dossier
New retinal tissue from skin samples.
Text: Christoph Dieffenbacher / To better understand certain eye diseases, researchers are recreating human retinas in the lab. To accomplish this, they create tissue cultures known as organoids from human skin and blood cells.
-
Dossier
Eyesight thanks to gene therapy.
Text: Yvonne Vahlensieck / Stargardt disease is a hereditary condition that leads to the loss of sharp vision at a young age. In Basel, scientists and clinicians are working together to develop a gene therapy treatment for the disease. The method is expected to be available for clinical trials within a few years.
-
Dossier
Cell type atlas is an eye-opener
Text: Samuel Schlaefli / For the first time ever, researchers at the University of Basel have been able to show in detail that retinal tissue grown from induced pluripotent stem cells provides a suitable model for drug research. Key to this breakthrough was close collaboration between the Institute of Molecular and Clinical Ophthalmology Basel and University Hospital Basel.
-
Dossier
Treating glaucoma.
Text: David Herrmann / Among people over 50, one in 50 will suffer from glaucoma, which can lead to a loss of vision if left untreated. The Eye Clinic at the University Hospital Basel has been making major contributions to research into the condition.